Cargando…
CDKN2A methylation in esophageal cancer: a meta-analysis
CDKN2A is a tumor suppressor gene and is frequently inactivated in human cancers by hypermethylation of its promoter. However, the role and diagnostic value of CDKN2A methylation in esophageal cancer (EC) remains controversial. Therefore, we performed a meta-analysis, including data from 42 articles...
Autores principales: | Zhou, Chongchang, Li, Jinyun, Li, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564829/ https://www.ncbi.nlm.nih.gov/pubmed/28637022 http://dx.doi.org/10.18632/oncotarget.18412 |
Ejemplares similares
-
The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis
por: Li, Jinyun, et al.
Publicado: (2016) -
Prognostic and clinicopathological value of Twist expression in esophageal cancer: A meta-analysis
por: Song, Wen-Peng, et al.
Publicado: (2022) -
Risks and Benefits of Multimodal Esophageal Cancer Treatments: A Meta-Analysis
por: Sun, Lei, et al.
Publicado: (2017) -
Outcomes of curative esophageal cancer surgery in elderly: A meta-analysis
por: Baranov, Nikolaj S, et al.
Publicado: (2021) -
Diagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis
por: Hu, Haochang, et al.
Publicado: (2018)